In a shocking moment at the White House on Friday, Dr. Mehmet Oz rushed to assist pharmaceutical executive Gordon Findlay after he suddenly collapsed during a live press conference in the Oval Office.

The event, attended by several top health officials and business leaders, was intended to celebrate a new public–private initiative to expand access to GLP-1 medications—a breakthrough class of drugs used to treat obesity and diabetes.

Findlay, who had just been introduced and was speaking about the long-term health and economic benefits of the new drugs, appeared to lose his balance mid-sentence. He paused, then slumped over as colleagues and Secret Service agents reacted immediately.

Dr. Oz, who was seated in the front row as a medical consultant for the event, quickly jumped from his chair and ran to Findlay’s side. According to eyewitnesses, Oz checked the executive’s pulse and asked staff to call for medical assistance.

After a tense few minutes, White House staff ushered reporters out of the room. A spokesperson later confirmed that Findlay was conscious and receiving care. “He suffered a medical episode but is now stable,” the statement read.

The incident abruptly ended what had been a high-profile announcement on healthcare innovation, attended by President Biden, pharmaceutical leaders from Eli Lilly and Nova Therapeutics, and key members of the administration’s health team.

While the President did not comment publicly afterward, officials say the administration remains committed to making life-saving drugs more affordable and accessible.

Dr. Oz, later speaking briefly to reporters, said only:

“I did what any doctor would do. I’m just grateful he’s okay.”